A detailed history of Burkehill Global Management, LP transactions in Celcuity Inc. stock. As of the latest transaction made, Burkehill Global Management, LP holds 27,500 shares of CELC stock, worth $2.54 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
27,500
Holding current value
$2.54 Million
% of portfolio
0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$12.58 - $62.68 $345,950 - $1.72 Million
27,500 New
27,500 $1.36 Billion

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $1.38B
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Burkehill Global Management, LP Portfolio

Follow Burkehill Global Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burkehill Global Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Burkehill Global Management, LP with notifications on news.